# LEXICON PHARMACEUTICALS INC (LXRX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/LXRX/

- Reporting holders: 3
- Reported value: $2.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $1.8K | 957 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $285 | 152 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $4 | 2 | 0.0% | 12 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $2.1K |
| Q2 2026 | 152 | $901.9M |
| Q1 2026 | 136 | $508.1M |
| Q4 2025 | 123 | $300.9M |
| Q3 2025 | 124 | $348.7M |
| Q2 2025 | 124 | $244.6M |
| Q1 2025 | 129 | $122.9M |
| Q4 2024 | 130 | $220.8M |
| Q3 2024 | 136 | $455.8M |
| Q2 2024 | 126 | $479.8M |
| Q1 2024 | 119 | $434.8M |
| Q4 2023 | 105 | $286.9M |